CHANGES IN THE CD4 COUNTS, HEMOGLOBIN AND BODY WEIGHT IN PATIENTS WITH HIV ALONE AND HIV- TB CO-INFECTION

Authors

  • DINAKAR KR Post Graduate, Department of Pharmacology, JJM Medical College, Davangere - 577004Karnataka, India.
  • NARENDRANATH SANJI Associate Professor of Pharmacology, JJM Medical College, Davangere. 3Professor of Pharmacology, JJM Medical College, Davangere
  • VANEET AGGARWAL Post Graduate Student, Department of Pharmacology, JJM Medical College, Davangere.
  • RESHMA SR Post Graduate Student, Department of Pharmacology, JJM Medical College, Davangere.
  • SOMASHEKAR HS Associate Professor of Pharmacology, JJM Medical College, Davangere. 3Professor of Pharmacology, JJM Medical College, Davangere
  • KEERTHISAGAR J Post Graduate Student, Department of Pharmacology, JJM Medical College, Davangere

Abstract

Objectives:  To assess the changes in the CD 4 counts, hemoglobin and weight in patients co-infected with HIV/Tb receiving anti-retroviral therapy and anti-tubercular therapy. To compare the changes of these parameters between the group receiving ART alone and the group receiving ART and ATT.

Methodology: Retrospective data was collected from the ART centre, Chigateri Hospital, Davangere, Karnataka. Patients on any one HAART regimen for atleast six months were compared against patients receiving both HAART and ATT. Changes in the CD4 counts, hemoglobin levels and weight were analyzed with statistical tests.

Results: Data from the records of 506 HIV patients were analyzed out of which 90 had tuberculosis. There was a significant improvement in the CD4 counts of both the groups with treatment (HIV:p=0.0001; co-infection:p=0.0001) but the mean improvement did not vary in either groups (HIV:138.71 cells; co-infection:138.58 cells). The hemoglobin did not improve significantly in either group (HIV:p=0.2485; co-infection:p=0.2966) but the mean hemoglobin improvement in the HIV alone group was better (HIV:2.69g%; co-infection:0.41g%). There was an improvement of weight in both the groups with treatment (HIV:p=0.042;co-infection:p=0.0004) but the mean weight improvement was better in co-infection group (HIV:1.86kgs; co-infection:3.36kgs).

Conclusion: In our study all the parameters improved in both the groups. Presence of Tb did not influence the improvement in CD4 counts. The weight improved significantly in both the groups, which was very significant in the co-infection group. The rise in the hemoglobin levels was not statistically significant.

 

Key words: CD4 counts, Hemoglobin, Body Weight, HIV-TB coinfection.

Downloads

Download data is not yet available.

Author Biography

DINAKAR KR, Post Graduate, Department of Pharmacology, JJM Medical College, Davangere - 577004Karnataka, India.

Post Graduate, Department of Pharmacology.

References

HIV/AIDS. Global Health Observatory. Global situation and trends. [Online]. Cited on 4/11/2013. Available from: URL:www.who.int/gho/hiv/en/

HIV/AIDS. [Online]. Cited on 4/11/2013. Available from: URL:www.unicef.org/india/children_2358.htm

Global facts and figures. Report on global AIDS epidemic. UNAIDS. Aug; 2008.

Soumya Swaminathan, Narendran G. HIV and tuberculosis in India. J Biocsi 2008;33:527-537.

Pradeep Seth. The situation of HIV/Mycobacterium tuberculosis co-infection in India. The Open Infectious Diseases Journal 2011; 5:Suppl(1-M5):51-59

Anti-retroviral therapy guidelines for HIV infected adults and adolescents including post-exposure prophylaxis. Ministry of health and family welfare. Government of India. May; 2007.

Lawn SD, Badri M, Wood R, town C. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005 Aug, 19:2109-2116.

Surendra K Sharma. Zidovudine Induced anaemia in HIV/AIDS. Indian J Med Res 132, Oct 2010: 359-361.

Steven Grinspoon, Kathleen Mulligan. Weight loss and wasting in patients infected with human immunodeficiency virus. Clinical Infectious Diseases 2003;36(suppl 2):69-78.

Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. American Thoracic Society;1995 Jan 1;151(1):129-35.

Wanke C. Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy. AIDS 2003 Jan;17 Suppl 4:112-114.

Harris RJ, Sterne JA, Abqrall S, Dabis F, Reiss P, Saaq M et al. Prognostic importance of anaemia in HIV type – 1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 2008;13(8):959-67.

Saathoff E, Villamor E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW. Anemia in adults with tuberculosis is associated with HIV and anthropometric status in Dar es Salaam, Tanzania. Int J Tuberc Lung Disease 2011 July;15(7):925-932.

Lawson L, Yassin MA, Thacher TD, Olatunji OO, Lawson JO, Akingbogun TI et al. Clinical presentation of adults with pulmonary tuberculosis with and without HIV infection in Nigeria. Scand J Infect Dis 2008 Jan 1;40(1):30-35.

Lucas SB, De Cock KM, Hounnou A, Peacock C, Diomande M, Honde M, et al. Contribution of tuberculosis to slim disease in Africa. BMJ 1994;308:1531-1533.

Published

01-05-2014

How to Cite

KR, D., N. SANJI, VANEET AGGARWAL, R. SR, SOMASHEKAR HS, and K. J. “CHANGES IN THE CD4 COUNTS, HEMOGLOBIN AND BODY WEIGHT IN PATIENTS WITH HIV ALONE AND HIV- TB CO-INFECTION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 7, no. 7, May 2014, pp. 35-38, https://journals.innovareacademics.in/index.php/ajpcr/article/view/991.

Issue

Section

Articles